These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 18717757
1. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites. Kim SU, Han KH, Nam CM, Park JY, Kim DY, Chon CY, Ahn SH. J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757 [Abstract] [Full Text] [Related]
3. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A. Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502 [Abstract] [Full Text] [Related]
4. The natural history of hepatitis B virus cirrhosis after the first hepatic decompensation in Tunisia. Jmaa A, Ksiaa M, Ben Slama A, Kahloun A, Jmaa R, Harrabi I, Golli L, Ajmi S. Tunis Med; 2012 Feb; 90(2):172-6. PubMed ID: 22407631 [Abstract] [Full Text] [Related]
6. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents. Kim CH, Um SH, Seo YS, Jung JY, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121 [Abstract] [Full Text] [Related]
10. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. Bruno S, Saibeni S, Bagnardi V, Vandelli C, De Luca M, Felder M, Fracanzani AL, Prisco C, Vitaliani G, Simone L, Gaeta GB, Stanzione M, Persico M, Furlan C, Stroffolini T, Salerno F, Maisonneuve P, Almasio PL, AISF (Italian Association for the Study of the Liver) – EPA-SCO Collaborative Study Group. Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467 [Abstract] [Full Text] [Related]
13. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization. Yoo SH, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY. Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589 [Abstract] [Full Text] [Related]
14. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites. Ra G, Tsien C, Renner EL, Wong FS. J Clin Gastroenterol; 2015 Dec; 49(10):858-65. PubMed ID: 25811112 [Abstract] [Full Text] [Related]
15. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications]. Gentilini P, Laffi G, La Villa G, Casini-Raggi V, Romanelli RG, Buzzelli G, Mazzanti R, Marra F, Pinzani M, Zignego AL. Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817 [Abstract] [Full Text] [Related]
16. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
18. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis]. Zhang JY, Kuai JH, Jia JD, Wang BE, Qin CY. Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023 [Abstract] [Full Text] [Related]
19. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. Planas R, Ballesté B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, Santos J, Coll S, Morillas RM, Solà R. J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231 [Abstract] [Full Text] [Related]